With an increasing understanding of the underlying pathogenetic mechanisms and identification of specific therapeutic targets, monoclonal antibody treatment has been an ideal strategy for inducing ...

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...

The Boston-area company’s previous raises were also aimed at getting its investigational antibody treatment for inclusion ...

Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

It helps in preventing severe bird flu in monkeys. A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on ...

BOSTON, MA / ACCESS Newswire / February 13, 2025 / Medisafe, the leading digital health and patient engagement platform, is proud to announce the launch of PATHWAYS, a new, complimentary tool designed ...

The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day's high of $1.11. The stock announced breaking news on its Monoclonal Antibody designed to ...